Articles by Brad Dixon

We found 2 results.

The 21st Century Cures Act: A Gift to the US Pharmaceutical Industry
Brad Dixon | WSWS – TRANSCEND Media Service, 12 Dec 2016

12 Dec 2016 – The 21st Century Cures Act is an early Christmas gift from the US Congress to the pharmaceutical and medical device industries. The bill guts the regulatory powers of the Food and Drug Administration, weakening the standards used to judge the safety and efficacy of drugs and medical devices. Notably, the bill does nothing to address skyrocketing drug prices.

→ read full article

Pfizer Gobbles Up Cancer Drug Maker in $14 Billion Deal
Brad Dixon | WSWS – TRANSCEND Media Service, 29 Aug 2016

25 Aug 2016 – Drugmaker Pfizer is set to acquire the biotech company Medivation for $14 billion. The primary aim of the deal was to secure Medivation’s cancer drug Xtandi in order to better position Pfizer within the lucrative market for oncology medications. Numerous drug companies have been circling around Medivation since April, like sharks after raw meat, including Sanofi, Merck, Celgene and Gilead, as well as Pfizer.

→ read full article